Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?

Orchid Pharma gets US nod for Naratriptan Tabs ANDA

Related News

The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Naratriptan Tablets in the 1 mg and 2.5 mg strengths.

Naratriptan tablets are the generic equivalent of GSK’s Amerge tablets.

Read more on:   
|

Read More

Sterling Holiday Resorts turns EBITDA Positive

The quarterly Total Operating Income of the Company was reported as Rs 278.0 million, as compared to Rs 127.3 million for the same period of the ...

Back to Top

Quick Links

Back to Top